封面
市场调查报告书
商品编码
1458006

全球胃肠出血治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Gastrointestinal Bleeding Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 222 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2032 年,全球胃肠出血治疗市场的市场规模将从 2023 年的 551.49 万美元达到近 942.87 万美元,2024-2032 年研究期间CAGR为 6.14%。

胃肠道出血治疗涉及解决消化道出血问题,消化道出血可能由多种疾病引起,例如溃疡、憩室病或胃肠道肿瘤。治疗方法可能包括内视镜介入、药物治疗,或在严重的情况下,透过外科手术来控制出血并解决根本原因。及时诊断和治疗对于预防併发症和确保患者健康至关重要。这种疾病的治疗是根据出血的部位和严重程度来製定的,以止血并促进癒合。

市场动态

在医疗保健领域的多种因素的推动下,胃肠道出血治疗市场正在经历显着成长。胃肠道出血性疾病的发生率不断上升,通常与消化性溃疡和发炎性肠道疾病等疾病有关,这推动了对有效治疗方案的需求。医疗技术的进步,包括内视镜手术和介入放射学,有助于改善诊断和微创治疗方法。全球人口老化,容易出现胃肠道问题,进一步促进了市场的成长。此外,慢性病盛行率的不断上升和抗凝血药物的使用增加了胃肠道出血的风险,因此需要及时有效的治疗方案。对早期检测和介入的重视以及新疗法的开发增强了胃肠道出血治疗市场的活力。总而言之,胃肠道疾病盛行率不断上升、医疗干预技术进步以及人口老化对有效和及时治疗的需求推动了胃肠道出血治疗市场的发展。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球胃肠道出血治疗市场的各个细分市场进行了包容性评估。胃肠道出血治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

胃肠道出血治疗市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 内视镜止血装置(热装置、机械装置)
  • 封闭装置
  • 其他的

胃肠道部门

  • 上消化道
  • 下胃肠道

按最终用户

  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲胃肠出血治疗市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

  • 全球胃肠出血治疗市场份额(按地区)(代表性图)
  • 全球胃肠道出血治疗市场份额

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。胃肠出血治疗市场的主要参与者包括波士顿科学公司、奥林巴斯公司、CONMED 公司、库克集团、Ovesco Endoscopy AG、Erbe Elektromedizin GmbH、STERIS、US ​​Medical Innovations。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:胃肠出血治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 胃肠道部门的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球胃肠出血治疗市场分析:副产品

  • 按产品概述
  • 历史和预测数据
  • 按产品分析
  • 内视镜止血装置(热装置、机械装置)
  • 封闭装置
  • 其他的

第 6 章:全球胃肠出血治疗市场分析:依胃肠道划分

  • 胃肠道部门概述
  • 历史和预测数据
  • 胃肠道部门分析
  • 上消化道
  • 下胃肠道

第 7 章:全球胃肠出血治疗市场分析:依最终使用者分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

第 8 章:全球胃肠出血治疗市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章:胃肠出血治疗公司的竞争格局

  • 胃肠出血治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章:公司简介

  • 公司股份分析
  • 市场集中度
  • Boston Scientific Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Olympus Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • CONMED Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cook Group
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Ovesco Endoscopy AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Erbe Elektromedizin GmbH
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • STERIS
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • US Medical Innovations
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中,财务详细资讯和近期发展视情况而定,或者如果是私人公司,则可能不包括在内

Product Code: VMR112113917

The global demand for Gastrointestinal Bleeding Treatment Market is presumed to reach the market size of nearly USD 942.87 MN by 2032 from USD 551.49 MN in 2023 with a CAGR of 6.14% under the study period 2024 - 2032.

Gastrointestinal bleeding treatment involves addressing bleeding in the digestive tract, which can result from various conditions, such as ulcers, diverticulosis, or gastrointestinal tumors. Treatment approaches may include endoscopic interventions, medication, or, in severe cases, surgical procedures to control bleeding and address the underlying cause. Prompt diagnosis & treatment are crucial to prevent complications and ensure patient well-being. Treatment for this disorder is tailored based on the location and severity of the bleeding to stop hemorrhage and promote healing.

MARKET DYNAMICS

The gastrointestinal bleeding treatment market is witnessing significant growth driven by multiple factors within the healthcare landscape. The rising incidence of gastrointestinal bleeding disorders, often linked to conditions such as peptic ulcers and inflammatory bowel diseases, propels the demand for effective treatment options. Advances in medical technologies, including endoscopic procedures and interventional radiology, contribute to improved diagnosis and minimally invasive treatment approaches. The aging global population, susceptible to gastrointestinal issues, further amplifies the market's growth. Furthermore, the escalating prevalence of chronic diseases and the use of anticoagulant medications elevate the risk of gastrointestinal bleeding, necessitating prompt and efficient treatment solutions. The emphasis on early detection and intervention and the development of novel therapies enhance the gastrointestinal bleeding treatment market dynamics. In summary, the gastrointestinal bleeding treatment market is driven by the escalating prevalence of gastrointestinal disorders, technological advancements in medical interventions, and the aging demographics contributing to the demand for effective and timely treatments.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gastrointestinal bleeding treatment. The growth and trends of gastrointestinal bleeding treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the gastrointestinal bleeding treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Endoscopic Hemostatic Devices (Thermal Devices, Mechanical Devices)
  • Closure Devices
  • Others

By GI Tract Division

  • Upper GI Tract
  • Lower GI Tract

By End-User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Gastrointestinal Bleeding Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

  • GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
  • Global Gastrointestinal Bleeding Treatment Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Gastrointestinal Bleeding Treatment market include Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Group, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS, US Medical Innovations. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . GASTROINTESTINAL BLEEDING TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By GI Tract Division
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Endoscopic Hemostatic Devices (Thermal Devices, Mechanical Devices) Historic and Forecast Sales by Regions
  • 5.5 Closure Devices Historic and Forecast Sales by Regions
  • 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET ANALYSIS BY GI TRACT DIVISION

  • 6.1 Overview by GI Tract Division
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by GI Tract Division
  • 6.4 Upper GI Tract Historic and Forecast Sales by Regions
  • 6.5 Lower GI Tract Historic and Forecast Sales by Regions

7 . GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-user
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-user
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Clinics Historic and Forecast Sales by Regions
  • 7.6 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE GASTROINTESTINAL BLEEDING TREATMENT COMPANIES

  • 9.1. Gastrointestinal Bleeding Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF GASTROINTESTINAL BLEEDING TREATMENT INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Boston Scientific Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Olympus Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. CONMED Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Cook Group
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Ovesco Endoscopy AG
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Erbe Elektromedizin GmbH
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. STERIS
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. US Medical Innovations
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Endoscopic Hemostatic Devices (Thermal Devices, Mechanical Devices) Market Sales by Geography (USD MN)
  • Closure Devices Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by GI Tract Division (USD MN)
  • Upper GI Tract Market Sales by Geography (USD MN)
  • Lower GI Tract Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Gastrointestinal Bleeding Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Gastrointestinal Bleeding Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Gastrointestinal Bleeding Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by GI Tract Division
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Endoscopic Hemostatic Devices (Thermal Devices, Mechanical Devices) Market Sales by Geography (USD MN)
  • Closure Devices Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by GI Tract Division (USD MN)
  • Upper GI Tract Market Sales by Geography (USD MN)
  • Lower GI Tract Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.